Bio Techne Stock Current Ratio
| T1CH34 Stock | 13.08 0.36 2.68% |
Bio Techne fundamentals help investors to digest information that contributes to Bio Techne's financial success or failures. It also enables traders to predict the movement of Bio Stock. The fundamental analysis module provides a way to measure Bio Techne's intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to Bio Techne stock.
Bio |
Bio Techne Company Current Ratio Analysis
Bio Techne's Current Ratio is calculated by dividing the Current Assets of a company by its Current Liabilities. It measures whether or not a company has enough cash or liquid assets to pay its current liability over the next fiscal year. The ratio is regarded as a test of liquidity for a company.
Typically, short-term creditors will prefer a high current ratio because it reduces their overall risk. However, investors may prefer a lower current ratio since they are more concerned about growing the business using assets of the company. Acceptable current ratios may vary from one sector to another, but the generally accepted benchmark is to have current assets at least as twice as current liabilities (i.e., Current Ration of 2 to 1).
| Competition |
In accordance with the recently published financial statements, Bio Techne has a Current Ratio of 0.0 times. This is 100.0% lower than that of the Healthcare sector and 100.0% lower than that of the Biotechnology industry. The current ratio for all Brazil stocks is 100.0% higher than that of the company.
Bio Current Ratio Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses Bio Techne's direct or indirect competition against its Current Ratio to detect undervalued stocks with similar characteristics or determine the stocks which would be a good addition to a portfolio. Peer analysis of Bio Techne could also be used in its relative valuation, which is a method of valuing Bio Techne by comparing valuation metrics of similar companies.Bio Techne is currently under evaluation in current ratio category among its peers.
Bio Fundamentals
| Return On Equity | 0.15 | |||
| Return On Asset | 0.0771 | |||
| Profit Margin | 0.23 % | |||
| Operating Margin | 0.26 % | |||
| Current Valuation | 73.29 B | |||
| Shares Outstanding | 4.72 B | |||
| Price To Book | 7.19 X | |||
| Price To Sales | 65.05 X | |||
| Revenue | 1.11 B | |||
| Gross Profit | 758.09 M | |||
| EBITDA | 413.76 M | |||
| Net Income | 272.05 M | |||
| Total Debt | 243.41 M | |||
| Book Value Per Share | 0.38 X | |||
| Cash Flow From Operations | 325.27 M | |||
| Earnings Per Share | 0.28 X | |||
| Number Of Employees | 3 K | |||
| Beta | 1.21 | |||
| Market Capitalization | 60.28 B | |||
| Total Asset | 2.29 B | |||
| Annual Yield | 0 % | |||
| Net Asset | 2.29 B | |||
| Last Dividend Paid | 0.32 |
About Bio Techne Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze Bio Techne's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Bio Techne using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Bio Techne based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.Other Information on Investing in Bio Stock
Bio Techne financial ratios help investors to determine whether Bio Stock is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Bio with respect to the benefits of owning Bio Techne security.